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Abstract
Protein kinase C (PKC) plays key roles in the regulation of signal transduction and cellular 
function in various cell types. At least ten PKC isoforms have been identified and intracellular 
localization and trafficking of these individual isoforms are important for regulation of enzyme 
activity and substrate specificity. PKC can be activated at downstream of Gq-protein coupled 
receptor (GqPCR) signaling and translocated to the various cellular compartments including 
plasma membrane (PM). Recent reports suggested that a different type of GqPCRs would activate 
different PKC isoforms (classic, novel and atypical PKCs) with different trafficking patterns. 
However, the knowledge of isoform-specific activation of PKC by each GqPCR is limited. α1-
Adrenoceptor (α1-AR) is the one of the GqPCR highly expressed in the cardiovascular system. In 
this study, we examined the isoform-specific dynamic translocation of PKC in living HEK293T 
cells by α1-AR stimulation (α1-ARS). Rat PKCα, βI, βII, δ, ε and ζ fused with GFP at C-term 
were co-transfected with human α1A-AR into HEK293T cells. The isoform-specific dynamic 
translocation of PKC in living HEK293T cells by α1-ARS using phenylephrine was measured by 
confocal microscopy. Before stimulation, GFP-PKCs were localized at cytosolic region. α1-ARS 
strongly and rapidly translocated a classical PKC (cPKC), PKCα, (< 30s) to PM, with PKCα 
returning diffusively into the cytosol within 5 min. α1-ARS rapidly translocated other cPKCs, 
PKCβI and PKCβII, to the PM (<30s), with sustained membrane localization. One of novel PKCs 
(nPKCs), PKCε, but not another nPKC, PKCδ, was translocated by α1-AR stimulation to the PM 
(<30s) and its membrane localization was also sustained. Finally, α1-AR stimulation did not cause 
a diacylglycerol-insensitive atypical PKC, PKCζ translocation. Our data suggest that PKCα, β and 
ε activation may underlie physiological and pathophysiological responses of α1-AR signaling for 
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the phosphorylation of membrane-associated substrates including ion-channel and transporter 
proteins in the cardiovascular system.
INTRODUCTION
Protein kinase C (PKC) is a multi-gene family of serine/threonine kinase that plays key roles 
in the regulation of signal transduction and cellular function in various cell-types/tissues 
[1-4]. PKC forms a multi-gene family and at least 10 PKC isoforms have been identified 
that differ in primary structure, tissue distribution, subcellular localization and substrate 
specificity [1-4]. These isoforms can be sub-grouped into three subfamilies. Members of the 
first family (include PKCα, βI, βII and γ) are regulated by Ca2+, diacylglycerol (DAG) and 
phospholipids, and are known as Ca2+-dependent PKCs [or classical PKCs (cPKC)]; 
members of the second family (include PKCδ,ε, η and θ) have phospholipid-dependent but 
Ca2+-independent activation mechanism, and are known as Ca2+-independent PKCs or 
novel PKCs (nPKC); members of the third family (include PKCζ and ι/λ) are not regulated 
by either intracellular Ca2+ concentration or phospholipid and their activity are maintained 
by other mechanisms (e.g. by protein-protein interactions), and are known as atypical PKCs 
(aPKC). Intracellular localizations of these individual isoforms are important for regulation 
of isoform-specific enzyme activity and substrate specificity [2,3]. Since the stimulation of 
GqPCRs such as α1-adrenoceptor (α1-AR), endothelin-1 receptor or angiotensin II receptor 
can generate DAG and also mobilize cytosolic Ca2+ elevation by releasing Ca2+ from the 
intracellular stores by stimulating inositol trisphosphate (IP3) receptors [5], cPKC and nPKC 
isoforms, but not aPKC are located downstream of GqPCR signaling pathways. Growing 
evidence suggests that stimulation of different GqPCRs exhibits receptor-specific pattern of 
activation and translocation of PKC isoforms [3]. However, since prior research 
investigating PKC translocation were mostly conducted using general PKC activators, such 
as phorbol esters [3], the knowledge of receptor-specific regulation of PKC-isoform 
activation/translocation is still incomplete.
One of GqPCRs, α1-AR, is stimulated by catecholamines (norepinephrine and epinephrine) 
[6-9]. α1-AR is expressed in variety of human tissue [10] and α1-AR stimulation has been 
shown to play important roles in cellular physiological functions, such as 1) regulation of 
smooth muscle contraction and tone in vascular system [9], prostate, urethra, bladder [11], 
uterine [12] and iris [13], 2) myocardial inotropy and chronotropy [14], 3) hepatic glucose 
metabolism [15], 4) water secretion at salivary gland [16] and 5) neurotransmission in 
central nerve system [9]. In addition, chronic α1-AR stimulation leads to pathophysiological 
responses in the various cells/tissues via both cPKC and nPKC isoform signaling pathways, 
including cardiac hypertrophy [17,18], hypertension and atherosclerosis [19,20] in 
cardiovascular system and portal hypertension and fibrosis in liver [21]. Despite strong 
interest in the mechanism underlying α1-AR signaling-mediated pathology, especially in 
cardiovascular system, little is known about the molecular mechanisms for the PKC 
isoform-specific kinetics of activation and translocation.
Here we examined the isoform-specific dynamic translocation of PKC in live HEK293T 
cells by α1-AR stimulation using GFP-tagged PKC isoforms, especially monitoring their 
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translocation to the plasma membrane (PM). We tested six PKC isoforms (α, βI, βII, δ, ε and 
ζ) in this study which are endogenously expressed in this cell line [22]. Our results show that 
PKCα, βI, βII and ε are able to be translocated to the PM upon α1-AR stimulation, while 
PKCδ did not show any significant PM translocation upon α1-ARS, although all isoforms 
are translocated to PM by a common PKC activator, phorbol 12-myristate 13-acetate (PMA) 
with a relatively slow time course. Our data suggest that PKCα, βI, βII and ε activation may 
underlie physiological responses of α1-AR signaling. In addition, due to a prolonged 
retention of PKCβI, PKCβII and PKCε at PM by α1-AR stimulation, these isoforms may be 
particularly important for the cellular pathophysiology in various cell types including 
cardiovascular system during chronic α1-AR stimulation.
MATERIAL AND METHODS
An expanded Material and methods section is available in the online supplementary file.
Live cell imaging
HEK293T cells and stable HEK293T cell line [23] carrying HA-tagged α1A-AR 
(Supplementary Fig.1) were transfected with GFP-tagged and/or DsRed2-tagged PKC 
isoforms and used for experiments 48 hours after transfection [24,25]. Time-dependent 
changes in localization of PKC isoforms by either phenylephrine (Phe) or PMA stimulation 
in HEK293T cells was measured using laser scanning confocal microscopy (Olympus, 
Tokyo Japan) without fixation at room temperature [25,26]. PM localization of PKC isoform 
was quantified by line scan intensity measurements through each cell beginning in the 
cytosol region (avoiding the nucleus area) and ending at the cell periphery. Translocation of 
each PKC isoform was evaluated by fluorescence intensity ratio between membrane and 
cytosolic region (membrane/cytosol ratio: M/C ratio) [25,26].
Statistical Analysis
All results are shown as mean ± standard error (SE). One-way ANOVA followed by 
Dunnet’s test (for multiple comparison) and paired-T-test (for two-group comparison) were 
done with the significance level set at P<0.05.
RESULTS
PKCα transiently translocates to the PM in response to α1-ARS
We co-expressed a GFP-tagged Ca2+-dependent PKC isoform PKCα with α1A-AR in 
HEK293T cells, stimulated the cells with a specific α1-AR agonist 100 μM Phe, and 
observed time-dependent changes in the subcellular localization of PKCα upon Phe 
stimulation (Fig.1A). Prior to stimulation (0 min), PKCα-GFP mainly localized in cytosol, 
with no nuclear localization (Fig.1A and B). After Phe stimulation PKCα-GFP rapidly 
translocated to the cell membrane (less than 30s) and gradually returned to cytosol. PKCα 
localization was restored within 5 min despite continuous Phe stimulation. This PKC 
translocation was completely blocked by the α1-AR-selective antagonist, 1 μM prazosin 
(Fig.1B and Supplementary Fig.2). We also tested the effect of PKC activator PMA on 
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PKCα-GFP translocation. PKCα-GFP showed relatively slower translocation to PM by 
PMA treatment compared to Phe (Fig.1B and Supplementary Fig.2).
As a control experiment, we co-expressed GFP with α1A-AR in HEK293 cells and 
confirmed that GFP localization did not alter by Phe stimulation (Supplementary Fig.3).
PKCβI and PKCβII translocate to the PM in response to α1-ARS
We next co-expressed other Ca2+-dependent PKC isoforms (GFP-tagged PKCβI or PKCβII) 
with α1A-AR in HEK293T cells and observed time-dependent changes in the subcellular 
localization of each PKC isoform by Phe (Fig.1C to F). Prior to stimulation, both PKCβI and 
PKCβII were localized in the cytosol, with no nuclear localization. Phe stimulation induced 
translocation of both PKCβI and PKCβII to the PM rapidly (after 30 sec) and PM 
localization was maintained throughout the course of the Phe application. Both PKCβI-GFP 
and PKCβII-GFP showed slower translocation to the PM by a PKC activator PMA treatment 
compared to Phe stimulation (Fig.1D and F), which is a similar time course as the one 
observed in PKCα (see Fig.1B). Interestingly, magnitude of PKCβII translocation by Phe 
stimulation was larger than that of PKCβI (Fig.1D and F).
To confirm the different translocation dynamics of PKCβI and βII by either Phe or PMA, we 
stimulated cells expressing both GFP- and DsRed2-tagged PKCβs. To normalize the 
magnitude of signal inputs (namely receptor signals via the Gq-protein) between the 
individual cells, HEK293T cells stably overexpressing α1A-AR (α1A-AR-HEK293T cells) 
were used for these experiments (Supplementary Fig.1). First, we confirmed that GFP- and 
DsRed2-tagged PKCβII showed similar translocation profiles under Phe or PMA 
stimulations in α1A-AR-HEK293T (Fig.1G and H). Using α1A-AR-HEK293T cells co-
expressing PKCβI-GFP and DsRed2-PKCβII, we next confirmed that magnitude of PKCβII 
translocation by Phe stimulation was significantly larger than that of PKCβI (Fig.1I and J). 
In contrast, PMA stimulation induces larger translocation of PKCβI than that of PKCβII 
(Fig.1J).
PKCε but not PKCδ translocate to the PM in response to α1-ARS
We next tested whether Ca2+-independent PKC isoforms translocates to the PM by α1-ARS. 
We co-expressed GFP-tagged PKCδ or PKCε with α1A-AR in HEK293T cells and observed 
time-dependent changes in the subcellular localization of these PKC isoforms upon Phe 
application. Prior to stimulation, PKCδ was localized in cytosol (Fig.2A). Some cells have 
strong punctuated fluorescence areas around the nucleus (Supplementary Fig.4). No 
significant time-dependent changes were observed in the subcellular localization of PKCδ 
by Phe treatment (Fig.2A and B). As a positive control, we observed significant 
translocation of PKCδ in response to treatment with PMA in the same cells (Fig2A and B). 
After PMA treatment, PKCδ was translocated from the cytosol to the PM and also to the 
nuclear membrane (Fig.2A, 2B and supplementary Fig.4). We also confirmed the lack of 
GFP-tagged PKCδ translocation by Phe using α1A-AR-HEK293T cells co-transfected with 
DsRed2-PKCβII (Fig.2C). In contrast, PKCε was significantly translocated from the cytosol 
to the PM 3 min after Phe stimulation and its PM localization was maintained during the 
course of the Phe application (Fig.2D and E). Magnitude of GFP-tagged PKCε translocation 
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by 10-min Phe stimulation was larger than that in PKC βI and also reached to the similar 
level of that in PKCβII (see Fig.1D and F). To quantitatively compare the translocation 
levels of PKCε and PKCβI by Phe, we stimulated α1A-AR-HEK293T cells expressing both 
GFP-PKCε and DsRed2-tagged PKCβI. The magnitude of PKCε translocation was 
consistently higher after Phe stimulation than that of PKCβI when measured in the same cell 
(Fig.2F, left). In contrast, PMA stimulation induces similar translocation profiles in these 
PKC isoforms (Fig.2F, right).
PKCζ does not show any translocation in response to α1-ARS
Finally, we tested whether DAG- and PMA-insensitive isoform (aPKC) change its 
subcellular localization in response to α1-ARS. We co-expressed one of the aPKC isoform 
PKCζ in HEK293 cells and monitored time-dependent changes in the subcellular 
localization of PKCζ upon Phe application. Prior to stimulation, PKCζ was localized in 
cytosol and no nuclear localization was observed (Fig. 3). There was no significant time-
dependent change in the subcellular localization of PKCζ by α1-ARS.
DISCUSSION
In this study, we examined the translocation profiles of PKC isoforms to the PM in live cells 
expressing GFP- and DsRed2-tagged PKC isoforms upon α1-AR stimulation. One 
advantage of using fluorescence protein-tagged PKC expression system is the ability to 
obtain more precise and quantitative spatiotemporal kinetics information on PKC activation 
and translocation profiles compared to classical methods, including Western blotting of 
fractionated proteins and the immunocytochemstry of fixed cells using isoform-specific 
antibodies [2,3]. Our results clearly indicate that each PKC isoform shows a different 
spatiotemporal pattern of translocation under α1-ARS (Fig. 4). We found the significant 
translocation of Ca2+-dependent PKCs (α, βI and βII) and one Ca2+-dependent PKC (PKCε) 
to the PM in response to α1-AR stimulation, which may underlie acute responses of α1-AR 
signaling at the PM. However, subcellular localization of another Ca2+-dependent PKC, 
PKCδ was not significantly modified by α1-ARS in the current experiments, despite 
showing a strong response to PMA (Fig.2).
Physiological and pathophysiological functions of each PKC isoform are diverse even 
though their substrate specificity is low and multiple isoforms are expressed in each cell-
type [2,3]. For instance, in the human myocardium, PKCα was the most abundant isoform 
present [19; 20] and PKCα activation has been linked to heart failure, hypertrophy and 
diabetes [21-27]. However, subsequent studies in genetic models of PKCα overexpression 
or knockout in mice failed to yield significant role of PKCα in generating hypertrophy to 
PKCα, identifying a more predominant role for PKCα in the regulation of cardiac 
contraction [28]. On the other hand, expression level of Ca2+-dependent PKCβ increases in 
the cardiovascular system during disease states. PKCβ activation has been linked to 
increased vascular inflammation and atherosclerosis [29]. In addition, genetic models 
showed that PKCβ expression is not necessary for the development of cardiac hypertrophy 
nor does its absence attenuate the hypertrophic response [30]. PKCε has been suggested to 
have a protective role in myocardial ischemia-reperfusion injury [31] and arrhythmias [32]. 
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Moreover, the use of specific PKC isoenzyme blockers may lead to novel treatments for 
heart failure [35; 36] and also for cancers [33] and Alzheimer’s disease [34]. Targeting PKC 
to the PM is crucial for the phosphorylation of membrane-associated substrates, including 
ion-channel and transporter proteins [27]. PMA is one of the well recognized activators of 
DAG-sensitive PKC subfamilies and is frequently used to mimic GqPCR signaling for 
investigating the effect of PKC translocation [2,3] to the PM, including in the studies for the 
regulation of ion channel function. However, we showed in live cells that the translocation 
kinetics of PKCs are largely different in response to either PMA treatment or receptor 
stimulation. First, α1-AR stimulation by Phe initiates PKC translocation much faster than 
PMA started (≅ 30 sec after stimulation). Second, while GqPCR-mediated PKCα 
translocation to the PM is transient, PMA treatment induces this isoform to be retained at the 
PM (Figs.1 and 4). Finally, isoform-specificity is also different between GqPCR and PMA 
responses; PMA caused sustained translocation of all DAG-sensitive isoforms tested to the 
PM (Figs.1 and 2), while α1-AR-mediated PKCδ translocation to the PM was not observed 
(Fig.2). This observation is consistent with previous data showing that connexin43, a gap 
junction channel protein, can be phosphorylated by PMA treatment through both PKCδ and 
PKCε [28,29], but PKCδ does not likely phosphorylate Connexin43 under GqPCR 
stimulation [30]. Thus, these results indicate that great caution is required when extending 
the results obtained with general PKC activators to PKC isoform activation by more 
physiological signaling pathways.
While we did not observe significant PKCδ translocation by α1-AR stimulation from cytosol 
to the PM using transfected PKCδ-GFP, our data does not exclude the possibility that PKCδ 
can be activated by α1-AR stimulation and translocated to the other cellular compartments 
including mitochondria and nucleus. For instance, Newton and colleagues detected a 
relatively small but significant PKCδ translocation to the outer mitochondrial membrane 
(OMM) after the application of a phorbol ester using fluorescence resonance energy (FRET) 
by generating an OMM-targeted [31] CFP (mt-CFP) and PKCδ-GFP [32]. They also 
confirmed that PKCδ activity was increased at the OMM upon phorbol-ester stimulation, 
using the OMM-targeted FRET-based PKCδ kinase activity reporter. Taken together, the 
data suggest that GqPCR stimulation may activate and translocate PKCδ to other 
intracellular compartments, but not to PM.
In summary, we showed that α1-AR induces PKCα, PKCβ and PKCε translocation to the 
PM, but not PKCδ and PKCζ by tracking the subcellular localization of transfected GFP-
tagged PKC after Phe stimulation. In addition, we found that kinetics of α1-AR-mediated 
activation of PKCs is isoform-specific. Our data suggests that activation of PKCα, PKCβ 
and PKCε may underlie physiological and pathophysiological responses of α1-AR signaling 
for the phosphorylation of PM-localized proteins such as ion channels and transporters.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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α1-AR α1-adrenoceptor
α1A-AR-HEK293T cells HEK293T cells stably overexpressing α1A-AR
aPKC atypical protein kinase C
cPKC classical protein kinase
DAG diacylglycerol
nPKC novel protein kinase
Phe phenylephrine
GqPCR Gq-protein coupled receptor
M/C ratio membrane/cytosol ratio
PKC protein kinase C
PM plasma membrane
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Highlights
• Isoform-specific translocation pattern of PKC was observed in live cells.
• PKCα, βI, βII, and ε translocates to plasma membrane by α1-adrenergic 
stimulation.
• PKCδ did not show any translocation to plasma membrane by α1-adrenergic 
stimulation.
• PKC translocation kinetics were different between PMA and α1-adrenergic 
stimulation.
• PKCα, βI, βII and ε may underlie physiological responses of α1-adrenergic 
signaling.
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Fig.1. Ca2+-dependent PKC isoforms translocate to the PM in response to α1-ARS
A. Representative cell images (top) and fluorescence intensity profiles at white dot lines 
(bottom) in cells expressing α1A-AR and PKCα-GFP during Phe stimulation. A.U., 
fluorescence arbitrary units. B. Time-dependent changes in the subcellular localization of 
PKCα-GFP by Phe in the presence or in the absence of α1-AR antagonist prazosin. The 
effect of PMA is also shown. *p<0.05, compared to control (0 min, before Phe 
stimulation). #p<0.05, compared to control (0 min, before PMA stimulation). C. 
Representative cell images (top) and fluorescence intensity profiles (bottom) in cells 
expressing α1A-AR and PKCβI-GFP during Phe stimulation. D. Time-dependent changes in 
the subcellular localization of PKCβI-GFP by Phe in the presence or in the absence of α1-
AR antagonist prazosin. The effect of PMA is also shown. *p<0.05, compared to control (0 
min, before Phe stimulation). #p<0.05, compared to control (0 min, before PMA 
stimulation). E. Representative cell images (top) and fluorescence intensity profiles (bottom) 
in cells expressing α1A-AR and PKCβII-GFP during Phe stimulation. F. Time-dependent 
changes in the subcellular localization of PKCβII-GFP by Phe in the presence or in the 
absence of α1-AR antagonist prazosin. The effect of PMA is also shown. *p<0.05, compared 
to control (0 min, before Phe stimulation). #p<0.05, compared to control (0 min, before 
PMA stimulation). G. Representative cell images and fluorescence intensity profiles in α1A-
AR-HEK293T cells co-expressing PKCβII-GFP and DsRed2-PKCβII during Phe 
stimulation. H. Time-dependent changes in the subcellular localization of PKCβII-GFP and 
DsRed2-PKCβII by Phe (top) or PMA (bottom) in α1A-AR-HEK293T cells. I. 
Representative cell images and fluorescence intensity profiles in α1A-AR-HEK293T cells 
co-expressing PKCβI-GFP and DsRed2-PKCβII during Phe stimulation. J. Time-dependent 
changes in the subcellular localization of PKCβI-GFP and DsRed2-PKCβII by Phe (top) or 
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PMA (bottom) in α1A-AR-HEK293T cells. *p<0.05, compared to PKCβI-GFP at each time 
point.
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Fig.2. Ca2+-independent PKC, PKCε does (but PKCδ does not) translocate to the plasma 
membrane in response to α1-ARS
A. Representative cell images (top) and fluorescence intensity profiles at white dot lines 
(bottom) in cells expressing α1A-AR and PKCδ-GFP during Phe stimulation. PKC δ 
translocation by PMA treatment was also observed in same cell as a positive control (right) 
(see also Supplementary Fig.4). A.U., fluorescence arbitrary units. B. Time-dependent 
changes in the subcellular localization of PKCδ-GFP by the treatment of Phe or 
PMA. #p<0.05, compared to control (0 min, before PMA stimulation). C. Left, 
representative cell images (top) and fluorescence intensity profiles at white dot lines 
(bottom) in α1A-AR-HEK293T cells co-transfected with PKCδ-GFP and DsRed2-PKCβII 
before and after Phe stimulation. The results shown are representative of five cells. Right, 
representative cell images (top) and fluorescence intensity profiles at white dot lines 
(bottom) in α1A-AR-HEK293T cells co-transfected with PKCδ-GFP and DsRed2-PKCβII 
before and after PMA stimulation. The results shown are representative of six cells. A.U., 
fluorescence arbitrary units. D. Representative cell images (top) and fluorescence intensity 
profiles at white dot lines (bottom) in cells expressing α1A-AR and PKCε-GFP during Phe 
stimulation. E. Time-dependent changes in the subcellular localization of PKCε-GFP by 100 
μM Phe in the presence or in the absence 1 μM prazosin. The effect of PMA is also shown 
as a positive control. *p<0.05, compared to control (0 min, before Phe stimulation). #p<0.05, 
compared to control (0 min, before PMA stimulation). F. Time-dependent changes in the 
subcellular localization of PKCε-GFP and DsRed2-PKCβI by Phe (left) or PMA (right) in 
α1A-AR-HEK293T cells. *p<0.05, compared to DsRed2-PKCβI at each time point.
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Fig.3. Atypical PKC, PKCζ does not show any translocation by α1-ARS
Representative cell images (top) and fluorescence intensity profiles at white dot lines 
(bottom) in cells expressing α1A-AR and PKCζ-GFP during α1-ARS (100 μM Phe). The 
results shown are representative of four cells. A.U., fluorescence arbitrary units.
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Fig.4. Isoform-specific translocation of PKC by α1-ARS in HEK293Tcells
A. Summary table of the Isoform-specific translocation of PKC by α1-ARS (Phe treatment) 
or PMA treatment in HEK293Tcells. B. Summary of the time-dependent translocation of 
PKC isoforms to the PM by α1-ARS in HEK293T cells. M/C ratio in each isoform was 
normalized by that obtained after 10-min application of PMA (set as a 100% translocation).
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